Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 81

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 3
Chunk 81
---
 resulting in costly clean-up and liabilities under applicable
laws and regulations governing the use, storage, handling and disposal of these materials and specified waste products. Although we believe
that the safety procedures utilized by our third-party manufacturers for handling and disposing of these materials generally comply with
the standards prescribed by these laws and regulations, we cannot guarantee that this is the case or eliminate the risk of accidental
contamination or injury from these materials. In such an event, we may be held liable for any resulting damages, such liability could
exceed our resources, and state or federal or other applicable authorities may curtail our use of certain materials and/or interrupt our
business operations. Furthermore, environmental laws and regulations are complex, change frequently and have tended to become more stringent.
We cannot predict the impact of such changes and cannot be certain of our future compliance. We do not currently carry biological or hazardous
waste insurance coverage.

Our business, operating results and growth rates may be adversely
affected by current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions
and associated liquidity risk.

Our business depends on the economic health of
the global economies. If the conditions in the global economies remain uncertain or continue to be volatile, or if they deteriorate, including
as a result of the impact of military conflict, such as the war between Russia and Ukraine and the security situation in Israel, terrorism
or other geopolitical events, our business, operating results and financial condition may be materially adversely affected. Economic weakness,
inflation and increases in interest rates, limited availability of credit, liquidity shortages and constrained capital spending have at
times in the past resulted, and may in the future result, in challenging and delayed sales cycles, slower adoption of new technologies
and increased price competition, and could negatively affect our ability to forecast future periods, which could result in an inability
to satisfy demand for our products and a loss of market share.

In addition, increases in inflation raise our costs
for commodities, labor, materials and services and other costs required to grow and operate our business, and failure to secure these
on reasonable terms may adversely impact our financial condition. Additionally, increases in inflation, along with the uncertainties surrounding
geopolitical developments and global supply chain disruptions, have caused, and may in the future cause, global economic uncertainty and
uncertainty about the interest rate environment, which may make it more difficult, costly or dilutive for us to secure additional financing.
A failure to adequately respond to these risks could have a material adverse impact